CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −15,890 | 47,670 | ||
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −17,100 | 0 | ||
| 2025-07-15 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-07-15 | Lewis William Chair and CEO | Sale 10b5-1 | −2,168 | $101.71 | $221K | 238,586 |
| 2025-07-15 | Lewis William Chair and CEO | Sale 10b5-1 | −4,492 | $102.66 | $461K | 234,094 |
| 2025-07-15 | Lewis William Chair and CEO | Sale 10b5-1 | −170 | $103.32 | $18K | 233,924 |
| 2025-07-15 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,830 | 13,695 | ||
| 2025-07-15 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −933 | $102.51 | $96K | 66,394 |
| 2025-07-11 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −748 | $96.41 | $72K | 67,327 |
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Option exercise 10b5-1 | +6,244 | $19.74 | $123K | 100,137 |
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Option exercise 10b5-1 | +4,362 | $24.70 | $108K | 104,499 |
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Option exercise 10b5-1 | +23,565 | $26.43 | $623K | 128,064 |
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Option exercise 10b5-1 | +13,717 | $26.46 | $363K | 141,781 |
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −35,583 | $95.66 | $3.4M | 106,198 |
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −22,181 | $96.19 | $2.1M | 84,017 |
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,244 | 18,880 | ||
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −4,362 | 0 | ||
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −23,565 | 15,710 | ||
| 2025-07-07 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −13,717 | 12,023 | ||
| 2025-07-01 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
Page 20 of 23 · 448 trades